Ajax-Loading

Takeda Pharmaceutical Co. Ltd. - Total Stockholder Equity

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.

The item "Total-Stockholder-Equity" stands at 7.13 Trillion Japanese Yens as of 09/30/2025.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Total Stockholder Equity" stands at 7.13 Trillion JPY. This represents an increase of 3.87 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 3.04 percent compared to the value the year prior.
The 1 year change in percent is 3.04.
The 3 year change in percent is 6.23.
The 5 year change in percent is 52.83.
The 10 year change in percent is 226.79.

The Serie's long term average value is 3.88 Trillion Japanese Yens. It's latest available value, on 09/30/2025, is 83.65 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2016, to it's latest available value, on 09/30/2025, is +281.52%.
The Serie's change in percent from it's maximum value, on 06/30/2024, to it's latest available value, on 09/30/2025, is -8.56%.

Total Stockholder Equity for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Total Stockholder Equity905,699,262,464.00
LogoJohnson & Johnson - Total Stockholder Equity486,508,953,600.00
LogoAbbVie Inc - Total Stockholder Equity399,570,305,024.00
LogoRoche Holding AG - Total Stockholder Equity317,433,206,677.55
LogoAstraZeneca PLC - Total Stockholder Equity280,205,508,085.11